PathMaker Neurosystems Inc., a clinical-stage neuromodulation company focused on non-invasive therapies for neuromotor disorders, recently announced that the U.S. Food and Drug Administration (FDA) has granted the company’s MyoRegulatorâ„¢ PM-2200 system the Expedited Access Pathway (EAP) designation and priority processing status. The MyoRegulator is the first product of PathMaker…
Muscle weakness
Flex Pharma Presenting Data on Promising Muscle Cramp Therapeutic Agent FLX-787 at Neuroscience 2015
Flex Pharma, Inc., a biotechnology company focused on therapies for muscle cramps and spasms associated with neuromuscular conditions, recently announced that it will present new data on its therapeutic agent FLX-787 at the 2015 Annual Meeting of the Society for Neuroscience, currently taking place in Chicago (October 17–21).
A new study recently published in the journal PLOS ONE revealed that high intensity exercise is safe and offers clinical benefits for patients with multiple sclerosis (MS). The study is entitled “High Intensity Exercise in Multiple Sclerosis: Effects on Muscle Contractile Characteristics and Exercise…
Singer Kristen King began to experience fatigue, muscle weakness and later paralysis in some parts of the body in 2013, and it came as a shock when she was diagnosed with multiple sclerosis (MS). After struggling to deal with the unfortunate news and her new reality, the singer has now…
Recommended Posts
- Pain linked to perceived cognitive difficulties in MS study
- Navigating mood changes in everyday life with MS
- Vitamin D-related gene changes tied to movement symptoms in MS
- Vitamin D, curcumin combination may help regulate immune cells in MS
- Stem cell transplant may help reduce chronic inflammation in MS